With 10 million new monthly readers and more than 30 million monthly visitors, food blog Food Babe has a following that is growing fast.

But the blog is still a small one, and the size of its audience is shrinking.

And despite growing readership, Food Babe is facing some growing pains, too.

A couple of weeks ago, Food Babe was temporarily suspended after a blogger who called herself “Lil B” published an essay claiming to have found a way to increase the effectiveness of the drug zolpidem.

But on Tuesday, FoodBabe was back online, with its staff now on the job and with more than 10 million monthly readers.

In the essay, Lil B alleged that the drug she described in the essay was ineffective for the treatment of depression, and it was used inappropriately for a range of other disorders.

“You might think, ‘What are they talking about?'” says blogger and food activist Maryam Khoda.

“But it’s not like it’s a new drug.”

Zolpid is a class of drugs called selective serotonin reuptake inhibitors, or SSRIs, which are used to treat symptoms of depression.

They’re also used to control anxiety and other symptoms associated with depression.

The drugs are also used for treating pain and other conditions that can cause anxiety, such as migraines, fibromyalgia and asthma.

But when it comes to depression, SSRI drugs can have side effects that can be severe.

The most commonly reported side effect is sleepiness, which can last up to four days.

The side effects of SSRAs are also associated with more serious side effects.

In fact, researchers at the University of Florida found that almost half of people taking SSRIS have an abnormal sleep pattern.

It also turns out that many people who take the drugs are doing so in ways that are harmful to their health, including eating too much, sleeping too little and being overweight.

According to a new study, the majority of people who took SSRis during their lifetime were obese, while those who didn’t take them were less likely to be obese.

The new research, led by Dr. Brian M. Linn, a professor of psychiatry at the university, also found that about one-third of people took SSRI drugs for depression that didn’t actually help them.

“The drugs are used in the clinic to treat depression and anxiety and have other side effects,” says Linn.

“There’s a huge body of literature that shows that these drugs have a negative impact on our mental health.”

The study was published in the British Journal of Psychiatry.

In addition to the research by Linn and his colleagues, another group of researchers published a study in February that looked at the effectiveness and safety of some of the antidepressants that are commonly prescribed to treat people with depression and related disorders.

They found that those antidepressants weren’t effective for people with mild to moderate depression and were also associated more with adverse health outcomes than other antidepressants.

The study, led to by a researcher at the Department of Psychiatry at Mount Sinai, examined data from more than 300,000 people with depressive disorder in the United States and Canada, as well as a total of 2,000 participants in the US and Canada.

The participants in both studies were given an average of two to three antidepressant prescriptions each, according to a press release from the Mount Sinai study.

The researchers found that the antidepressants in both the US study and the Canadian study were ineffective for people who were less depressed.

For example, the antidepressant Zoloft was found to be more effective for patients who had depression of a moderate or severe level than it was for those with depression that was more severe.

But it was less effective for those who were moderately depressed, the researchers said.

And for people in the Canadian trial, the effectiveness was similar to what it was in the U.S. study.

A second study published in June in the journal Neurology looked at antidepressant drugs that are available in the NHS, and found that patients with depression were more likely to have side effect profiles that were different from patients with other depression disorders.

For instance, people who had been prescribed antidepressants were more than twice as likely to report suicidal thoughts and attempts than those who had not been prescribed them.

The antidepressants that were prescribed in the UK were also found to cause more side effects, and they were more effective than the antidepressants prescribed in Canada.

“If you want to know what the effects of antidepressants are, the first thing you have to do is look at their side effects in patients with mild depression,” says M. Kelly Stavropoulos, a research fellow at the Cochrane Collaboration who co-authored the UK study.

“It is a combination of side effects.”

Stavrophy is the lead author of the Canadian and US studies.

“These are drugs that have the potential to have long-term, clinically important health effects,” she says.